Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (Prostacyclin)

Chest

Volumn 114, Issue 1 SUPPL., 1998, Pages 80S-82S

  Humbert, M ^a   Sanchez, O ^a   Fartoukh, M ^a   Jagot, J L ^a   Sitbon, O ^a   Simonneau, G ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DIURETIC AGENT; PROSTACYCLIN;

CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG EFFECT; EXERCISE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MIXED CONNECTIVE TISSUE DISEASE; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 0031857677     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.1_Supplement.80S     Document Type: Conference Paper

References (10)

1. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 335:111-17
2. Higenbottam TW, Wheeldon D, Wells F, et al. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet 1984; 1:1046-47
3. Rubin LJ, Mendoza J, Hood M, et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial. Ann Intern Med 1990; 112:485-91
4. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334:296-301
5. Brundage BH. Pulmonary hypertension in collagen vascular disease. In: Fishman A. ed. The pulmonary circulation. Philadelphia: University of Pennsylvania Press. 1990; 353-58
6. Brenot F, Simonneau G. Risk factors for primary pulmonary hypertension. In: Rubin L, Rich S, eds. Primary pulmonary hypertension. New York: Marcel Dekker, 1997: 131-49
7. Salerni R, Rodnan GP, Leon DF, et al. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med 1977; 86:394-99
8. Ungerer RG, Tashkin DP, Furst D, et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983; 75:65-74
9. Stupi AM, Steen VD, Owens GR, et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29:515-24
10. Quismorio FP, Sharma O, Koss M. et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1984; 13:349-59